Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
The importance of vector abundance and seasonality
The objective of this document is to assess the degree to which estimates of vector abundance and seasonality, for each vector group, can be used to inform assessments of epidemiological concepts.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
Rapid risk assessment: Local transmission of dengue fever in France and Spain
In early October, nine cases of autochthonous dengue were confirmed in the EU, three in Spain and six in France, in three separate outbreaks. These are the first autochthonous dengue cases in continental EU/EEA Member States that were reported this year.
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – first update
This rapid risk assessment addresses the public health risk associated with the current Ebola virus disease outbreak in the Democratic Republic of the Congo and its implications for EU/EEA citizens. This is the first update of a rapid risk assessment originally produced on 9 August 2018.
Rapid risk assessment: Monkeypox cases in the UK imported by travellers returning from Nigeria, 2018
The risks assessed in this document are of the introduction and further spread of monkeypox in the EU/EEA, infection with regards to different settings (e.g. healthcare, community, etc.) and transmission through SoHO.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), 22nd update
This update of ECDC’s risk assessment on MERS-CoV was triggered by the detection of a case imported into the EU/EEA from the Kingdom of Saudi Arabia (KSA). In this update, we reassess the risk for EU/EEA residents.
Rapid risk assessment: Public health risks related to communicable diseases during the 2018 Hajj, Saudi Arabia, 19–24 August 2018
This document assesses the potential risk of outbreaks/transmission of communicable diseases during the 2018 Hajj.